Bahçeci Health Group, one of the major providers of fertility services in Türkiye, entered into transaction agreements for the strategic acquisition of its shares by FutureLife, a major pan-European provider of fertility, IVF and genetics services and backed by CVC Capital Partners and Hartenberg Holding. The completion of the transaction is subject to fulfilment of conditions precedent including the Turkish Competition Authority’s approval.
Paksoy is pleased to announce that a team led by partner Elvan Aziz, along with senior associates Pınar Babaoğlu and Deniz Benli Kandiyoti, is acting as Turkish counsel to Bahçeci Group in this transaction.
Share
Related persons
You can contact us for detailed information.



Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.
5 January 2026
We are pleased to announce the promotion of Sabri Kaya to Counsel, effective as of 1 January 2026
We extend our congratulations to Sabri Kaya on his well-deserved promotion to Counsel.
5 January 2026
We are pleased to announce the promotion of Doğuhan Uygun and Zekican Samlı to Partner, effective as of 1 January 2026
We extend our congratulations to Doğuhan Uygun and Zekican Samlı on their well-deserved promotion to Partner.
29 December 2025
Paksoy advised GAMA Enerji on the sale of İç Anadolu Natural Gas Combined Power Plant to SOCAR
Paksoy advised GAMA Enerji on the sale of İç Anadolu Natural Gas Combined Power Plant to SOCAR